- (1) When the Board receives information involving a licensee who may have a substance use and/or a mental health disorder, the Board staff will investigate and complete a report to be presented at a Board meeting.
(2) If the licensee meets eligibility criteria and the Board approves entry into the HPSP, the Board will provide a written referral. The referral must include:
- (a) A copy of the report from the independent clinical evaluator who diagnosed the licensee;
- (b) The treatment recommendations developed by the independent clinical evaluator;
- (c) A statement that the Board has investigated the licensee’s professional practice and conduct;
- (d) A description of any restrictions or requirements imposed by the Board or recommended by the Board on the licensee’s professional practice;
- (e) The licensee’s written agreement to enter the HPSP and to abide by all rules established by the Board and all terms and conditions established by the contractor; and
(f) A statement that the licensee has agreed to report:
- (A) Any arrest for or conviction of a misdemeanor or felony crime to the Board within three business days after the licensee is arrested or convicted.
- (B) Any citation for the use or possession of any DEA scheduled substances, including but not limited to citations for Class E violations, to the contractor within three business days of the citation.
- (3) The Executive Director or Medical Director has the authority to approve a licensee’s entry into the HPSP.
Statutory/Other Authority
ORS 676.190, 677.265 & 676.200
Statutes/Other Implemented
ORS 676.190, 676.185, 676.200, 676.194 & OL 2025, chapter 499, sections 2-3
History
OMB 4-2026, amend filed 01/12/2026, effective 01/12/2026
OMB 19-2022, amend filed 10/12/2022, effective 10/12/2022
OMB 33-2012, f. & cert. ef. 10-22-12
OMB 17-2012(Temp), f. & cert. ef. 7-31-12 thru 1-15-13
OMB 9-2011, f. & cert. ef. 4-25-11
BME 20-2010, f. & cert. ef. 10-25-10
BME 15-2010(Temp), f. & cert. ef. 8-3-10 thru 1-18-11